Patriot Financial Group Insurance Agency’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-31
Closed -$1K 1965
2020
Q4
$1K Buy
31
+13
+72% +$880 ﹤0.01% 1712
2020
Q3
$1K Buy
18
+3
+20% +$149 ﹤0.01% 1513
2020
Q2
$1K Buy
+15
New +$517 ﹤0.01% 1471

Other funds holding ARCT

Patriot Financial Group Insurance Agency's ARCT Position: Q1 2021 in Review

Patriot Financial Group Insurance Agency sold out of Arcturus Therapeutics (ARCT) in Q1 2021, closing a stake of 31 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in ARCT in Q2 2020 and held it in 3 quarters. The position peaked at $1K in Q4 2020. 162 funds tracked by Wall St. Rank hold ARCT as of Q1 2021.

  • Patriot Financial Group Insurance Agency reported no remaining Arcturus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 31 Arcturus Therapeutics shares in Q1 2021, an estimated $1K.
  • Patriot Financial Group Insurance Agency first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 3 quarters.
  • Patriot Financial Group Insurance Agency's Arcturus Therapeutics position peaked at $1K in Q4 2020.
  • 162 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2021.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2021, filed 29 Apr 2021.